{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:08:56Z","timestamp":1787508536646,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.ando.2016.01.007","type":"journal-article","created":{"date-parts":[[2016,6,20]],"date-time":"2016-06-20T14:22:17Z","timestamp":1466432537000},"page":"202-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["SFE\/SFHTA\/AFCE consensus on primary aldosteronism, part 3: Confirmatory testing"],"prefix":"10.1016","volume":"77","author":[{"given":"Yves","family":"Reznik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Amar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Tabarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2016.01.007_bib0005","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.HYP.0000079505.25750.11","article-title":"Primary aldosteronism and hypertensive disease","volume":"42","author":"Mosso","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.ando.2016.01.007_bib0010","first-page":"1863","article-title":"Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology","volume":"85","author":"Fardella","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.01.007_bib0015","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1210\/jc.2006-0078","article-title":"Comparison of confirmatory tests for the diagnosis of primary aldosteronism","volume":"91","author":"Mulatero","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.01.007_bib0020","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mce.2003.10.006","article-title":"Primary aldosteronism \u2013 careful investigation is essential and rewarding","volume":"31","author":"Stowasser","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ando.2016.01.007_bib0025","first-page":"28","article-title":"Increased disorderliness and amplified basal and pulsatile aldosterone secretion in patients with primary aldosteronism","volume":"80","author":"Siragy","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.01.007_bib0030","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1210\/jc.2002-021476","article-title":"Variability in the renin\/aldosterone profile under random and standardized sampling conditions in primary aldosteronism","volume":"88","author":"Tanabe","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.01.007_bib0035","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1210\/jc.2012-1917","article-title":"A clinical prediction score to diagnose unilateral primary aldosteronism","volume":"97","author":"K\u00fcpers","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.01.007_bib0040","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1097\/HJH.0b013e3283060f0c","article-title":"Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma","volume":"26","author":"Letavernier","year":"2008","journal-title":"J Hypertens"},{"key":"10.1016\/j.ando.2016.01.007_bib0045","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1210\/jc.2011-2504","article-title":"Confirmatory testing in primary aldosteronism","volume":"97","author":"Nanba","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.01.007_bib0050","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/HYPERTENSIONAHA.107.091827","article-title":"Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma","volume":"50","author":"Rossi","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ando.2016.01.007_bib0055","unstructured":"Amar L, Kuipers E, Raynaud A, Plouin PF, Steichen O. Suppressible aldosteronism on saline infusion test does not exclude lateralized primary aldosteronism. 22nd European meeting on hypertension and cardiovascular protection. 2012;3:576\u2013582."},{"key":"10.1016\/j.ando.2016.01.007_bib0060","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/ajh\/3.7.576","article-title":"Correctable subsets of primary aldosteronism. Primary adrenal hyperplasia and renin responsive adenoma","volume":"3","author":"Irony","year":"1990","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ando.2016.01.007_bib0065","first-page":"S103","article-title":"Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension","volume":"5","author":"Gordon","year":"1987","journal-title":"J Hypertens Suppl"},{"key":"10.1016\/j.ando.2016.01.007_bib0070","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1530\/EJE-11-0914","article-title":"Confirmatory testing in primary aldosteronism: extensive medication switching is not needed in all patients","volume":"166","author":"Solar","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2016.01.007_bib0075","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1373\/clinchem.2006.068502","article-title":"Automated chemiluminescence-immunoassay for aldosterone during dynamic testing: comparison to radioimmunoassays with and without extraction steps","volume":"52","author":"Schirpenbach","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.ando.2016.01.007_bib0080","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3317\/jraas.2001.022","article-title":"Diagnosis and management of primary aldosteronism","volume":"2","author":"Stowasser","year":"2001","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.ando.2016.01.007_bib0085","first-page":"39","article-title":"Laboratory investigation of primary aldosteronism","volume":"3","author":"Stowasser","year":"2010","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.ando.2016.01.007_bib0090","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2014-1153","article-title":"Seated saline suppression testing for the diagnosis of primary aldosteronism: a preliminary study","volume":"99","author":"Ahmed","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.01.007_bib0095","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1055\/s-0032-1314786","article-title":"Comparison of the saline infusion test and the fludrocortisone suppression test for the diagnosis of primary aldosteronism","volume":"44","author":"Willenberg","year":"2012","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.ando.2016.01.007_bib0100","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/HJH.0b013e328126856e","article-title":"Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma","volume":"25","author":"Rossi","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/j.ando.2016.01.007_bib0105","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/01.HYP.6.5.717","article-title":"Further evaluation of saline infusion for the diagnosis of primary aldosteronism","volume":"6","author":"Holland","year":"1984","journal-title":"Hypertension"},{"key":"10.1016\/j.ando.2016.01.007_bib0110","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1530\/eje.1.02164","article-title":"Confirmatory testing in normokalaemic primary aldosteronism: the value of the saline infusion test and urinary aldosterone metabolites","volume":"154","author":"Schirpenbach","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2016.01.007_bib0115","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1749-6632.2002.tb04413.x","article-title":"Primary aldosteronism: management issues","volume":"970","author":"Young","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ando.2016.01.007_bib0120","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0002-9343(83)91022-7","article-title":"The changing clinical spectrum of primary aldosteronism","volume":"74","author":"Bravo","year":"1983","journal-title":"Am J Med"},{"key":"10.1016\/j.ando.2016.01.007_bib0125","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/01.hjh.0000217857.20241.0f","article-title":"Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol","volume":"24","author":"Giacchetti","year":"2002","journal-title":"J Hypertens"},{"key":"10.1016\/j.ando.2016.01.007_bib0130","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/HYPERTENSIONAHA.107.093468","article-title":"Captopril test can give misleading results in patients with suspect primary aldosteronism","volume":"50","author":"Mulatero","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ando.2016.01.007_bib0135","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1210\/jcem-57-5-892","article-title":"Single dose captopril as a diagnostic test for primary aldosteronism","volume":"57","author":"Lyons","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.01.007_bib0140","first-page":"251","article-title":"Primary hyperaldosteronism: diagnostic value of the administration of a single dose of captopril","volume":"134","author":"Thibonnier","year":"1983","journal-title":"Ann Med Intern (Paris)"},{"key":"10.1016\/j.ando.2016.01.007_bib0145","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1161\/01.HYP.37.6.1440","article-title":"Captopril suppression versus salt loading in confirming primary aldosteronism","volume":"37","author":"Agharazii","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.ando.2016.01.007_bib0150","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/HJH.0b013e3282f4b3e6","article-title":"Primary aldosteronism: an update on screening, diagnosis and treatment","volume":"26","author":"Rossi","year":"2008","journal-title":"J Hypertens"},{"key":"10.1016\/j.ando.2016.01.007_bib0155","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.01.007_bib0160","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1507\/endocrj.EJ11-0133","article-title":"Guidelines for the diagnosis and treatment of primary aldosteronism \u2013 the Japan Endocrine Society 2009","volume":"58","author":"Nishikawa","year":"2011","journal-title":"Endocrine J"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426616000287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426616000287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:48:24Z","timestamp":1757717304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426616000287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0003426616000287"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2016.01.007","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SFE\/SFHTA\/AFCE consensus on primary aldosteronism, part 3: Confirmatory testing","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2016.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}